A comprehensive view of Capsules / Pills / Tablets. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

The FDA approves ViiV Healthcare’s Dovato (dolutegravir/lamivudine) for adolescents aged 12 and above for the treatment of HIV-1 infection; Dovato offers a single-tablet, two-drug oral regimen for HIV therapy

Evonik highlights its EUDRAGIT brand of polymers as key ingredients in coating systems for pharmaceuticals; company introduces EUDRACAP, an option for enteric capsule production

Upsher-Smith Laboratories launches Methimazole tablets, USP, 5 mg and 10 mg., in the US with potential market value of US$36.8M; original reference is Pfizer's brand Tapazole

Kobayashi Pharmaceutical's red yeast rice cholesterol-lowering supplement linked to five deaths due to kidney disease, prompting voluntary product recall and extensive investigations; over 100 people hospitalized after consuming the product

Sun Pharma's US branch recalls 55,272 bottles of febuxostat gout tablets due to microbial contamination at its Dadra, India, manufacturing facility; recall covers 40-milligram and 80-milligram dosages

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count